Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Join the brightest minds in regulatory at the annual Regulatory Convergence. See the global regulatory community in action. Intensive workshops. Topical sessions. Meet ups with regulators. This is where it all comes together.
With so many global regulation changes, staying informed is a challenge. Join other regulatory professionals as you navigate the gray together.
For 20 years, our flagship publication, Fundamentals of US Regulatory Affairs, has been giving regulatory professionals the insights and answers they need, right at their fingertips.
There are hundreds of RAC testing centers available worldwide. Either RAC exam (Devices and Drugs) may be taken at any location. Find an upcoming exam at a location near you.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.
Posted 21 March 2012 | By Alexander Gaffney, RAC
Life sciences manufacturer Johnson & Johnson sold its now-controversial vaginal mesh implant for three years prior to being approved by the US Food and Drug Administration (FDA) in 2008, reports Bloomberg.
The unauthorized sale of the Prolift vaginal mesh implant product, manufactured by Johnson & Johnson's Ethicon unit, could place the 510(k) approval pathway under additional scrutiny.
The company marketed Prolift as early as 2005, reports Bloomberg, reasoning that it was substantially equivalent to the already-approved Gynecare Gynemesh.
FDA "disagreed with this assertion," said FDA press officer Morgan Liscinsky, when FDA learned of the device in 2007, but still approved the product under the 510(k) pathway in 2008.
The company is currently embroiled in hundreds of lawsuit over the devices, which plaintiffs claim caused injury to them. The revelation about the unapproved sales of Prolift, could make it considerably harder to settle or win some of the lawsuit, said Bloomberg.
Read more:
Bloomberg - J&J Sold Vaginal Mesh Implant Without U.S. Regulatory Approval
Tags: Prolift, Vaginal Mesh, Bloomberg, J&J, Lawsuit, Implant, Johnson & Johnson, Latest News, 510(k), medical device
Regulatory Focus newsletters
All the biggest regulatory news and happenings.